William Hornung
Nessuna posizione attualmente
Profilo
William K.
Hornung worked as Vice President-Finance at PTC Therapeutics, Inc. from 2012 to 2014, and as Head-Strategic Planning & Operations at Elan Pharmaceuticals, LLC from 1998 to 2002.
He also served as Chief Financial Officer at Hepion Pharmaceuticals, Inc. in 2014-2015 and currently holds the position of Chief Financial Officer at Diffusion Pharmaceuticals, Inc. since 2018.
Hornung received his undergraduate degree from The William Paterson University of New Jersey in 1992.
Precedenti posizioni note di William Hornung
| Società | Posizione | Fine |
|---|---|---|
| DIFFUSION PHARMA | Direttore Finanziario/CFO | 15/05/2023 |
| HEPION PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 16/11/2015 |
| PTC THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/03/2014 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2002 |
Formazione di William Hornung
| The William Paterson University of New Jersey | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- William Hornung
